Unusual Synchronous Colonic Metastasis of Ovarian Cancer

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Jul 7

PMID 37416036

Authors

Laila Jaouani

Adil Zaimi

Ouissam Al Jarroudi

Anass Haloui

Fatima Rezzoug

Sami Aziz Brahmi

Said Afqir

Affiliations

Soon will be listed here.

Abstract

Colorectal metastasis is rare and can be confused with primary colorectal cancer. We report the case of a 63-year-old patient who presented with synchronous metastasis of the rectosigmoid junction and ovarian cancer. Initially thought to be a Krukenberg tumor, the diagnosis of metastasis from ovarian origin was confirmed through an immunohistochemical study of the colonic biopsy.

References

Reed E, Zerbe C, Brawley O, Bicher A, Steinberg S . Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988. Am J Clin Oncol. 2000; 23(2):107-16. DOI: 10.1097/00000421-200004000-00002. View

Burger R, Brady M, Bookman M, Fleming G, Monk B, Huang H . Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med. 2011; 365(26):2473-83. DOI: 10.1056/NEJMoa1104390. View

Loy T, Calaluce R, Keeney G . Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol. 1996; 9(11):1040-4. View

Liu Z, Zhang Y, Niu Y, Li K, Liu X, Chen H . A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer. PLoS One. 2014; 9(8):e103910. PMC: 4126674. DOI: 10.1371/journal.pone.0103910. View

Bois A, Luck H, Meier W, Mobus V, Costa S, Richter B . Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. Semin Oncol. 1997; 24(5 Suppl 15):S15-44-S15-52. View

Berhili S, El Khannoussi B, Kadiri S, Mezouri I, Bazine A, Touil A . Uterine cervix metastasis from a sigmoid adenocarcinoma: a rare presentation of an uncommon tumor. Gynecol Oncol Res Pract. 2016; 1:6. PMC: 4878055. DOI: 10.1186/2053-6844-1-6. View

Rekhi B, George S, Madur B, Chinoy R, Dikshit R, Maheshwari A . Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa. Diagn Pathol. 2008; 3:39. PMC: 2556647. DOI: 10.1186/1746-1596-3-39. View

Galanopoulos M, Gkeros F, Liatsos C, Pontas C, Papaefthymiou A, Viazis N . Secondary metastatic lesions to colon and rectum. Ann Gastroenterol. 2018; 31(3):282-287. PMC: 5924850. DOI: 10.20524/aog.2018.0244. View

Huang J, Xu L, Cheng G, Wu W, Tang W, Xu L . A case of rectal metastasis of ovarian carcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration: A case report and brief review of the literature (with videos). Clin Case Rep. 2021; 9(4):2276-2280. PMC: 8077282. DOI: 10.1002/ccr3.4011. View

10.

Dvoretsky P, Richards K, Bonfiglio T . The pathology and biologic behavior of ovarian cancer. An autopsy review. Pathol Annu. 1989; 24 Pt 1:1-24. View

11.

Wu P, Lang J, Huang R, Liu J, Tang M, Lian L . Intestinal metastasis and operation in ovarian cancer: a report on 62 cases. Baillieres Clin Obstet Gynaecol. 1989; 3(1):95-108. DOI: 10.1016/s0950-3552(89)80045-8. View

12.

El Bairi K, Al Jarroudi O, Afqir S . Tracing ovarian cancer research in Morocco: A bibliometric analysis. Gynecol Oncol Rep. 2021; 37:100777. PMC: 8192560. DOI: 10.1016/j.gore.2021.100777. View

13.

Akhtar K, Sherwani R, Anees A . Synchronous ovarian carcinoma with colorectal metastases: an unusual presentation. Clin Pract. 2014; 2(2):e53. PMC: 3981276. DOI: 10.4081/cp.2012.e53. View

14.

Aqsa A, Droubi S, Amarnath S, Haddad F, Deeb L . Colorectal Metastasis from Ovarian Neoplasm Mimicking Primary Colon Cancer. Case Rep Gastroenterol. 2021; 15(1):41-46. PMC: 7879281. DOI: 10.1159/000510934. View

15.

Takahashi K, Shibukawa T, Moriyama M, Shirai T, Kijima S, Iwanari O . Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer--a study on 674 patients. Jpn J Surg. 1986; 16(5):305-10. DOI: 10.1007/BF02470551. View

16.

Ledermann J, Raja F, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C . Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6:vi24-32. DOI: 10.1093/annonc/mdt333. View

17.

El Mehdi T, Essadi I, Mrabti H, Errihani H . Rare recurrence of a rare ovarian stromal tumor with luteinized cells: a case report. J Med Case Rep. 2011; 5:350. PMC: 3163610. DOI: 10.1186/1752-1947-5-350. View

18.

Friedlander M, Trimble E, Tinker A, Alberts D, Avall-Lundqvist E, Brady M . Clinical trials in recurrent ovarian cancer. Int J Gynecol Cancer. 2011; 21(4):771-5. DOI: 10.1097/IGC.0b013e31821bb8aa. View

19.

Lindner V, Gasser B, Debbiche A, Tomb L, Vetter J, Walter P . [Ovarian metastasis of colorectal adenocarcinomas. A clinico-pathological study of 41 cases]. Ann Pathol. 2000; 19(6):492-8. View

20.

Lengyel E . Ovarian cancer development and metastasis. Am J Pathol. 2010; 177(3):1053-64. PMC: 2928939. DOI: 10.2353/ajpath.2010.100105. View